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Polychlorinated biphenyls (PCBs) are 
a structurally related group of stable and 
highly lipophilic chemicals with widespread 
distribution in the environment (Hornbuckle 
et al. 2006). Despite being banned in 1977, 
PCBs persist in the environment, and high 
residue levels are still detected in human 
tissues (DeCaprio et al. 2005; Humphrey 
et al. 2000; Park et al. 2007). Epidemiologic 
data indicate that PCBs negatively impact 
neuropsychologic function in exposed chil­
dren (Carpenter 2006; Korrick and Sagiv 
2008; Schantz et al. 2003), and experimental 
animal studies confirm that developmental 
PCB exposure causes cognitive and psycho­
motor deficits (Mariussen and Fonnum 
2006). However, the cellular and molecular 
mechanisms mediating these effects remain 
speculative. 
PCBs interfere with endocrine functions, 
specifically those mediated by thyroid hor­
mone (Zoeller 2007) and estrogen (DeCastro 
et al. 2006; Dickerson and Gore 2007), 
and increase neuronal Ca2+ levels via several 
mechanisms (Kodavanti 2005; Mariussen and 
Fonnum 2006), including ryanodine receptor 
(RyR) activation (Pessah and Wong 2001). 
It is not clear, however, how these molecular 
effects relate to PCB developmental neuro­ 
toxicity. Thyroid hormone (Kapfhammer 
2004), estrogen (Cooke and Woolley 2005), 
and Ca2+ (Lohmann and Wong 2005; 
Redmond and Ghosh 2005) influence neuronal 
connectivity via dynamic control of dendritic 
structure. Altered patterns of dendritic growth 
and plasticity are associated with impaired 
behavior in experimental models (Berger­
Sweeney and Hohmann 1997) and are thought 
to contribute to diverse neurodevelopmen­
tal disorders (Connors et al. 2008; Pardo 
and Eberhart 2007; Zoghbi 2003), suggest­
ing the possibility that PCBs elicit develop­
mental neurotoxic effects by interfering with 
neuronal connectivity. 
Consistent with this hypothesis, we 
recently observed that developmental PCB 
exposure disrupts the balance of neuronal 
inhibition to excitation in the developing rat 
auditory cortex (Kenet et al. 2007) and accel­
erates dendritic growth in the hippocampus 
and cerebellum of weanling rats (Lein et al. 
2007). Questions yet to be addressed include 
the relationship between PCB interference 
with neuronal connectivity and known mole­ 
cular targets of PCBs and whether develop­ 
mental exposures to PCBs interfere with 
experience­dependent dendritic plasticity, a 
phenomenon critical to associative learning 
and memory (Leuner and Shors 2004). In 
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Background: Neurodevelopmental disorders are associated with altered patterns of neuronal con-
nectivity. A critical determinant of neuronal connectivity is the dendritic morphology of individual 
neurons, which is shaped by experience. The identification of environmental exposures that interfere 
with dendritic growth and plasticity may, therefore, provide insight into environmental risk factors 
for neurodevelopmental disorders. 
oBjective: We tested the hypothesis that polychlorinated biphenyls (PCBs) alter dendritic growth 
and/or plasticity by promoting the activity of ryanodine receptors (RyRs). 
Methods and results: The Morris water maze was used to induce experience-dependent neural 
plasticity in weanling rats exposed to either vehicle or Aroclor 1254 (A1254) in the maternal diet 
throughout gestation and lactation. Developmental A1254 exposure promoted dendritic growth 
in cerebellar Purkinje cells and neocortical pyramidal neurons among untrained animals but 
attenuated or reversed experience-dependent dendritic growth among maze-trained littermates. 
These structural changes coincided with subtle deficits in spatial learning and memory, increased 
[3H]-ryanodine binding sites and RyR expression in the cerebellum of untrained animals, and inhi-
bition of training-induced RyR upregulation. A congener with potent RyR activity, PCB95, but 
not a congener with negligible RyR activity, PCB66, promoted dendritic growth in primary cortical 
neuron cultures and this effect was blocked by pharmacologic antagonism of RyR activity. 
conclusions: Developmental exposure to PCBs interferes with normal patterns of dendritic 
growth and plasticity, and these effects may be linked to changes in RyR expression and function. 
These findings identify PCBs as candidate environmental risk factors for neurodevelopmental dis-
orders, especially in children with heritable deficits in calcium signaling. 
key words: dendrite, neurodevelopmental disorders, developmental neurotoxicity, PCBs,  plasticity, 
ryanodine receptor. Environ Health Perspect 117:426–435 (2009). doi:10.1289/ehp.11771 avail-
able via http://dx.doi.org/  [Online 12 September 2008]
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this study, we used the Morris water maze as a 
tool for inducing experience­dependent neural 
plasticity in weanling rats exposed to Aroclor 
1254 (A1254) in the maternal diet throughout 
gestation and lactation. In addition to assess­
ing dendritic morphology in these animals, we 
also quantified RyR expression and function, 
thyroid hormone levels, and developmental 
end points regulated by sex steroids. Our find­
ings suggest that developmental PCB exposure 
interferes with dendritic growth and plasticity 
coincident with delayed spatial learning and 
that perturbation of RyR expression and func­
tion contributes to these effects.
Materials and Methods
Detailed descriptions of all methods are avail­
able online in Supplemental Material (http://
www.ehponline.org/members/2008/11771/
suppl.pdf).
Animals and PCB exposures. Animals 
were treated humanely and with regard for 
alleviation of suffering according to protocols 
approved by the Institutional Animal Care 
and Use Committees of the Johns Hopkins 
University and Oregon Health & Science 
University. Adult Long Evans rats were 
purchased from Charles River Laboratories 
(Hollister, CA) and housed individually, 
except during breeding, in standard plastic 
cages with Alpha­Dri bedding (Shepherd 
Specialty Papers, Watertown, TN) in a tem­
perature­controlled (22 ± 2°C) room on a 
12­hr reverse light–dark cycle. Food and water 
were provided ad libitum. Dams used in the 
study delivered litters of 10–15 pups (n = 11 
dams per treatment group). By postnatal day 
2 (P2), litters were culled to five males and 
five females. Pups were weaned on P21. 
Dams were dosed with the commer­
cial PCB mixture Aroclor 1254 (A1254, lot 
#124­191; AccuStandard, New Haven, CT) 
at 1 mg or 6 mg/kg/day beginning 2 weeks 
prior to breeding and continuing until P21. 
A1254 was diluted in corn oil and pipetted 
onto one­half of a Keebler Golden Vanilla 
Wafer (Kellogg Company, Battle Creek, MI). 
Control animals received wafers dosed with 
an equal volume (500 µL) of vehicle. Doses 
were adjusted daily to account for changes in 
body weight of the dams. Dams were fed the 
wafers in a separate cage to prevent the pups 
from accessing the wafers and were watched 
carefully to ensure that the entire wafer was 
consumed (typically within 5 min). 
Tissue culture and transfection. High­
density cultures of dissociated neocorti­
cal neurons (105 cells/cm2) were prepared 
from P1 Sprague Dawley rats (Charles River 
Laboratories) and maintained in Neurobasal­A 
(Invitrogen, Carlsbad, CA) supplemented 
with B27 (Invitrogen) as previously described 
(Wayman et al. 2006). On day 6 in vitro 
(6­DIV) cultures were transfected with 
plasmid encoding a microtubule­associated 
protein­2 (MAP2)­enhanced green fluorescent 
protein (GFP) fusion construct (Wayman 
et al. 2006) using Lipofectamine­2000 
(Invitrogen) according to the manufacturer’s 
protocol. On 7­DIV, cultures were treated 
for 48 hr with vehicle (DMSO at 1:1,000 
dilution), PCB95 (2,2´,3,5´,6­pentachloro­
biphenyl, > 95% purity; AccuStandard), or 
PCB66 (2,3´,4,4´­tetrachlorobiphenyl, > 95% 
purity; AccuStandard).
Thyroid hormone assays. Total thyro­
xine (T4) and triiodothyronine (T3) levels 
were determined in serum samples by radio­
immunoassay (Diagnostic Products Corp, 
Los Angeles, CA) as previously described 
(Kodavanti et al. 1998).
Analysis of reproductive development. At 
P2, litter size, sex ratio, and pup body mass 
were measured. Anogenital distance (AGD) 
was measured at P2, P10, and P21. At P21, 
litters were weaned and housed with same­sex 
siblings. At P40 (puberty), body mass was 
measured, and the presence of preputial separa­ 
tion or vaginal opening was recorded in males 
and females, respectively. At P70, blood 
samples collected from the retro­orbital sinus 
were analyzed for serum levels of testosterone 
in males and estradiol in females by radio­
immunoassay per the manufacturer’s protocol 
[ICN Biochemicals, Inc. (MP Biomedical, 
Solon, OH)]. Samples were assayed in trip­
licate and cross­reactivity with other steroids 
was < 0.1%. After blood collection, animals 
were euthanized, and reproductive organs 
were removed and weighed. The tunica was 
then stripped from paired testes, and the 
seminiferous tubules were homogenized in 
0.5% Triton­X 100 with 0.01% thimerosal 
to determine sperm concentration using a 
Newbauer chamber.
Morris water maze. Spatial learning and 
memory was assessed on P24 in one male and 
one female from 11 different litters within each 
treatment group, using the Morris water maze 
as previously described (Jett et al. 1997). Rats 
were tested in one trial per day, except on the 
first day, when two trials were administered. 
This modification increases difficulty such that 
relatively small differences between treatment 
groups can be detected, yet the task is not too 
difficult for rats to learn quickly (Jett et al. 
1997, 2001; Kuhlmann et al. 1997). An escape 
latency of 10 sec was chosen as the criterion 
that animals had learned the task, based on 
previous studies using rats of comparable age 
in a similar size pool (Jett et al. 1997, 2001; 
Markwiese et al. 1998; Rudy et al. 1987). To 
test spatial memory, a probe test was admini­
stered 30 min after the spatial training trials 
on the first day that the mean escape latency of 
any treatment group reached criterion. 
Morphometric analyses. On P31, ani­
mals were euthanized and perfused with 4% 
paraformaldehyde. To visualize Purkinje cell 
dendritic arbors, parasagittal cryosections 
(12 µm) were cut from both cerebellar hemi­
spheres, starting 1 mm from the midline, and 
reacted with antibody specific for calbindin­
D28K (Sigma, St. Louis, MO), which specif­
ically labels Purkinje cells (Christakos et al. 
1987). Dendritic arbors of neocortical neurons 
were visualized by Golgi staining as previously 
described (Lein et al. 2007). Dendritic arbors 
were quantified in cultured neocortical neurons 
transfected with MAP2­eGFP as previously 
described (Wayman et al. 2006). An average of 
10 neurons per culture from three cultures per 
group was analyzed, and results were confirmed 
in two independent dissections. 
RyR profiling. Specific [3H]­ryanodine 
(5 nM) binding to whole particulate cerebel­
lar membranes was measured at P21 and P31, 
as previously described (Wong et al. 1997). 
Western blot analyses were used to quan­
tify RyR expression as previously described 
(Roegge et al. 2006). 
Cytochrome-P450 (CYP) activity. 
Hepatic CYP content was determined as pre­
viously described (Omura and Sato 1964). 
7­Ethyoxyresorufin O­deethylase (EROD) 
and 7­pentoxyresorufin O­depentylase 
(PROD) activities were analyzed in hepatic 
microsomes according to the method of Lubet 
(Lubet et al. 1990) as modified by Kennedy 
and Kono (Kennedy and Jones 1994; Kono 
et al. 1999). Enzyme activities were norma­ 
lized to protein concentration as deter­
mined using the BCA Protein Assay (Pierce, 
Rockford, IL). 
Congener-specific PCB analyses. Whole 
brains from P31 rats were stored at –80°C 
and thawed immediately before extraction, 
cleanup, and fractionation using gel perme­
ation chromatography as previously described 
(Sethajintanin et al. 2004). 
Results
Developmental A1254 exposure did not 
cause maternal or fetal toxicity. Consistent 
with previous reports (Roegge et al. 2004), 
dietary exposure of dams to A1254 at 1 mg 
or 6 mg/kg/day, starting 2 weeks before con­
ception and continuing throughout ges­
tation and lactation, did not negatively 
impact developmental outcomes or cause 
overt signs of intoxication in dams or pups 
as determined by lack of treatment­related 
changes in maternal weight gain during gesta­ 
tion, maternal body weight during lactation, 
length of gestation, litter size, and weight gain 
of offspring during lactation [see Supplemental 
Material (http://www.ehponline. org/ members/ 
2008/11771/suppl.pdf), Figure 1]. 
Effects of developmental A1254 exposure on 
thyroid hormone levels and sex steroid- dependent 
developmental end points. Developmental 
exposure to A1254 at 1 mg or 6 mg/kg/day 
Yang et al.
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significantly decreased serum concentrations of 
T4 and T3 at P21 (Figure 1). By P31, serum T3 
and T4 had recovered to control levels among 
pups in the 1 mg/kg/day A1254 treatment 
group, but were still significantly depressed in 
the 6 mg/kg/day treatment group. No sex differ­
ences were observed. 
As shown in Table 1, developmental 
A1254 exposure differentially altered a subset 
of reproductive developmental end points 
regulated by estrogens and androgens includ­
ing: a) male to female ratio of litters, which 
was increased in the 6 mg/kg/day A1254 
treatment group; b) absolute but not rela­
tive AGD among female offspring, which was 
longer than control in both A1254 treatment 
groups; c) vaginal opening, which was sig­
nificantly delayed among females in the 6 mg/
kg/day A1254 treatment group; and d) both 
absolute and relative prostate mass, which 
was increased in P70 males exposed to A1254 
at 1 mg/kg/day but not 6 mg/kg/day, in the 
maternal diet. A number of other sex steroid–
dependent developmental end points were not 
affected by developmental exposure to either 
dose of A1254, including AGD (absolute 
or relative) in males, preputial separation in 
males, the size of female reproductive organs, 
the size of male reproductive organs other 
than the prostate, sperm counts or plasma 
concentrations of estradiol in females and tes­
tosterone in males. 
Developmental A1254 exposure alters 
spatial learning and memory. The Morris 
water maze has been shown to detect subtle 
but significant changes in cognitive function 
in weanling rats exposed to developmental 
neurotoxicants (Jett et al. 1997, 2001; 
Markwiese et al. 1998), and training in this 
task induces experience­dependent dendritic 
growth (Greenough et al. 1979). Although 
considered a test of hippocampal function, 
performance in the Morris water maze is also 
dependent on the function of the cerebellum 
and neocortex (Lalonde and Strazielle 2003; 
Save and Poucet 2000), which is particularly 
relevant to the current studies because a) the 
vulnerability of the cerebellum to develop­
mental hypothyroidism (Dong et al. 2005) 
is proposed as a primary mechanism for PCB 
developmental neurotoxicity (Koibuchi and 
Iwasaki 2006; Roman 2007; Zoeller 2007); 
and b) our previous studies of molecular bio­
markers of dendritic growth (Lein et al. 2007) 
and development of excitatory to inhibitory 
balance in neurotransmission (Kenet et al. 
2007) indicated that neuronal connectivity in 
the neocortex may be particularly susceptible 
to modulation by PCBs. 
Training in the Morris water maze was 
initiated on P24 and concluded on P30 
(Figure 2). Repeated­measures two­way 
ANOVA, with sex and treatment as the 
between­subjects factors and trial day as the 
repeated­measures factor, identified a signifi­
cant interaction between treatment and trial 
(p < 0.001) but a lack of interaction of sex 
with treatment or trial. There was no three­
way interaction among trial, treatment, and 
sex. Subsequent post hoc Newman­Keuls 
multiple comparisons on each trial day 
revealed a significant difference in escape 
latency between the 1 mg/kg/day treatment 
group and both vehicle and 6 mg/kg/day 
treatment groups on day 4. Although signif­
icant differences between treatment groups 
were not detected on other trial days, it is clear 
from the plot of escape latency that from day 
3 through day 7, the 1 mg/kg/day treatment 
group took longer to find the platform than 
the control and 6 mg/kg/day treatment group 
(Figure 2A). The percentage of animals within 
each treatment group that reached criterion 
by the end of the training period was signifi­
cantly reduced in the 1 mg but not 6 mg/
kg/day treatment group relative to controls 
(Figure 2B), further suggesting that weanling 
rats exposed developmentally to A1254 at 
1 mg/kg/day were not as proficient at spatial 
learning as animals in either the control or 
6 mg/kg/day A1254 group. Spatial memory 
was assessed during the probe test on days 4 
and 7, the first day that controls and 1 mg/
kg/day–treated animals reached criterion, 
respectively. On day 4, the 1 mg/kg A1254 
rats spent significantly less time in the training 
quadrant than those from the control or 6 mg/
kg/day A1254 groups (Figures 2C and 2E). 
On day 7, however, there were no significant 
differences between groups (data not shown), 
suggesting that although learning and mem­
ory were impaired in the 1 mg/kg/day A1254 
group, with additional training, rats in this 
Figure 1. Developmental A1254 exposure decreases 
serum thyroid hormone levels. Developmental 
A1254 exposure caused significant dose- dependent 
decreases in total serum T4 and T3 at P21. This 
effect persisted in the 6 mg but not the 1 mg/kg/day 
A1254 treatment group at P31. No sex differences 
were observed. Data are presented as mean ± 
SEM (n = 7–9/group).
*p < 0.05 (two-way ANOVA, with treatment and sex as 
main effects; Fisher’s LSD post hoc).
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Table 1. Effects of developmental A1254 exposure on sex steroid-dependent reproductive developmental 
end points in rats.
   A1254 (mg/kg/day)
   0 1 6
Male:female ratioa  1.05 ± 0.12 1.07 ± 0.22 2.16 ± 0.42*
AGD (mm)a
 Male 
  P2 3.96 ± 0.14 4.16 ± 0.25 3.93 ± 0.11
  P10 7.70 ± 0.26 8.07 ± 0.36 7.76 ± 0.46
  P21 16.2 ± 0.53 16.9 ± 0.59 16.9 ± 0.63
 Female 
  P2 1.98 ± 0.08 2.05 ± 0.19 2.08 ± 0.21
  P10 5.14 ± 0.15 5.76 ± 0.21* 5.70 ± 0.27*
  P21 9.48 ± 0.29 9.39 ± 0.26* 8.82 ± 0.28*
Puberty (days)a 
 Males 
  Preputial separation 40.36 ± 0.28 40.45 ± 0.14 40.21 ± 0.08
 Females
  Vaginal opening 40.05 ± 0.05 40.50 ± 0.19 43.44 ± 1.07*
Adulthooda 
 Males
  Testesb (g) 2.98 ± 0.06 2.95 ± 0.11 3.11 ± 0.03
  Epididymal fat padb (g) 3.66 ± 0.13 3.44 ± 0.14 3.31 ± 0.33
  Epididymidesb (g)  0.73 ± 0.03 0.71 ± 0.02 0.69 ± 0.02
  Seminal vesiclesb (g) 0.23 ± 0.01 0.25 ± 0.02 0.23 ± 0.01
  Prostate glandb (g)  0.49 ± 0.02 0.57 ± 0.03* 0.41 ± 0.01
  Testosterone (ng/mL) 5.54 ± 0.87 4.53 ± 0.51 4.40 ± 0.81
  Sperm count (× 106) 10.40 ± 0.58 9.46 ± 1.15 11.22 ± 0.46
 Females
  Ovariesb (g) 0.12 ± 0.006 0.13 ± 0.009 0.12 ± 0.004
  Ovarian fat padb (g) 4.19 ± 1.04 2.43 ± 0.21 2.19 ± 0.27
  Uterine hornsb (g) 0.29 ± 0.01 0.37 ± 0.05 0.31 ± 0.05
  Estradiol (pg/mL) 65.43 ± 6.34 74.80 ± 4.30 68.94 ± 3.57
aMean ± SEM (n ≥ 30/group). bAbsolute organ mass. *p < 0.05. 
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group did acquire the task. Developmental 
exposure to A1254 at either dose had no effect 
on escape latency in the visual cue test or on 
swimming speed (Figure 2D), indicating that 
learning and memory deficits observed in the 
training trials and probe tests were not due to 
negative impacts of A1254 on vision, motiva­
tion, or swim speed. 
Developmental A1254 exposure inter-
feres with dendritic growth and plasticity. 
Morphometric analyses of Nissl­stained sec­
tions indicated no overt treatment­related 
effects on development of the cerebellum or 
neocortex [see Supplemental Material (http://
www.ehponline.org/members/2008/11771/
suppl.pdf), Figure 2]. To assess effects of 
developmental A1254 exposure on cellular 
indices of neural circuitry, dendritic length 
was quantified in individual cerebellar 
Purkinje cells and neocortical pyramidal neu­
rons at P31. Because no sex differences were 
observed in PCB effects on performance in 
the Morris water maze, morphometric studies 
were restricted to males. 
Morphometric analyses of cerebellar neu­
rons immunopositive for calbindin, which is 
a specific marker of Purkinje cells (Christakos 
et al. 1987), indicated that among untrained 
animals, developmental exposure to A1254 
at 1 mg but not 6 mg/kg/day significantly 
increased total dendritic length relative to 
vehicle controls (Figure 3A). Analysis of the 
percent change in dendritic length of cerebellar 
Purkinje cells as a function of maze training 
within groups revealed that Morris water maze 
training significantly increased total dendritic 
length in Purkinje cells of controls, caused sig­
nificant dendritic retraction in the 1 mg/kg/
day A1254 group, and had no significant effect 
on dendritic length among rats in the 6 mg/
kg/day A1254 group (Figure 3B). Comparison 
between groups indicated that training­induced 
dendritic growth observed among controls 
was significantly attenuated by developmental 
exposure to A1254 at 6 mg/kg/day and actually 
reversed by A1254 at 1 mg/kg/day (Figure 3B). 
Representative camera lucida drawings 
of the basilar dendritic arbor of neocorti­
cal pyramidal neurons from untrained and 
maze­trained littermates within each group 
(Figure 3C) demonstrate effects similar to 
those observed in cerebellar Purkinje cells. 
Quantification of dendritic length by Sholl 
analysis indicated that in untrained animals, 
developmental exposure to A1254 increased 
dendritic length in neocortical pyramidal neu­
rons by 20% and 17% in the 1 mg and 6 mg/
kg/day groups, respectively, relative to con­
trols. Maze training increased dendritic length 
of neocortical neurons among controls by 
22% but caused dendritic length to decrease 
by 17% in the 1 mg/kg/day A1254 treat­
ment group (Figures 3C and 3D). In animals 
exposed developmentally to A1254 at 6 mg/
kg/day, maze training caused neither signifi­
cant expansion nor retraction of the dendritic 
arbor relative to untrained littermates (Figures 
3C and 3D). Comparison between groups 
of the percent change in dendritic length of 
neocortical pyramidal neurons as a function 
of maze training indicated that the training­
induced dendritic growth observed in controls 
was inhibited by developmental exposure to 
A1254, with significantly more pronounced 
effects observed in the 1 mg versus 6 mg/kg/
day A1254 group (Figure 3D). 
Developmental A1254 exposure influ-
ences RyR profiles. One of the most sensitive 
molecular targets of PCBs is RyR activation 
(Pessah and Wong 2001). All three RyR iso­
forms are expressed in the brain, and RyR 
activity influences use­dependent synaptic 
plasticity (Berridge 2006). These observations 
suggest that PCBs may interfere with den­
dritic growth and plasticity via RyR­mediated 
mechanisms. To test this hypothesis, we first 
determined whether developmental A1254 
exposure influenced RyR function and 
expression. Because the effects of develop­
mental A1254 exposure on dendritic growth 
Figure 2. Developmental A1254 exposure at 1 mg but not 6 mg/kg/day impairs performance in the Morris water maze. (A) Escape latency as a function of trial. 
(B) Percentage of animals that reached criterion (escape latency ≤ 10 sec) during the 7-day training period. (C) Probe tests conducted on day 4. Dotted line indi-
cates predicted time spent in the training quadrant by chance alone. (D) Performance in visual cue test and swimming speed. (E) Representative swim paths from 
probe tests on day 4. Data are presented as mean ± SEM.
*p < 0.05, **p < 0.01 (A, repeated measures ANOVA; B, Fisher’s exact test; C and D, ANOVA; Newman-Keuls post hoc).
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and plasticity were similar between cerebellar 
Purkinje cells and neocortical pyramidal neu­
rons, these studies focused on the cerebellum. 
To measure the density and level of functional 
activation of RyR channels, we analyzed spe­
cific high­affinity binding of [3H]­ryanodine 
to membranes prepared from cerebella of 
males within each group. Scatchard analy­
sis of binding data obtained from cerebellar 
membranes of P21 animals indicated that 
developmental A1254 dose­dependently 
increased the [3H]­ryanodine binding den­
sity (Bmax) without significantly changing 
apparent affinities (KD) (Figures 4A and 4B). 
Comparison of these values to those obtained 
from [3H]­ryanodine binding to cere­ 
bellar membranes isolated from maze­trained 
P31 rats indicated that maze training did not 
affect the density of [3H]­ryanodine binding 
sites measured in controls, but significantly 
increased the density of functional RyR chan­
nels among animals exposed developmentally 
to A1254 at 1 mg or 6 mg/kg/day, with sig­
nificantly more pronounced effects observed 
at the higher dose (Figure 4C). 
[3H]­ryanodine binds with high affinity 
and specificity to all three RyR isoforms and 
is a measure of the expression levels of func­
tional RyR proteins as well as the stability of 
the open state of these channels (Buck et al. 
1992). To evaluate the effects of developmen­
tal A1254 exposure on specific RyR isoforms, 
we examined expression levels by Western 
blot using monoclonal antibodies (mAbs) that 
selectively bind to RyR1 and RyR3 (mAb 
34C) or to RyR2 (mAb C3­33) (Airey et al. 
1990; Lai et al. 1992). Both RyR1 and RyR2 
were observed in cerebellar membranes iso­
lated from P21 and P31 rats, but bands cor­
responding to the molecular weight of RyR3 
were not detected in any sample (Figure 5A). 
Developmental A1254 exposure increased 
RyR1 and RyR2 expression levels in the cere­ 
bellum of P21 rats (Figure 5B). Although 
Figure 3. Developmental A1254 exposure interferes with normal dendritic growth and experience-
 dependent dendritic plasticity. Dendritic morphology was analyzed among P31 rats trained in the Morris 
water maze (Maze) and among littermates identically housed and exposed but not trained (Nonmaze). 
(A) Total dendritic length of cerebellar Purkinje cells in nonmaze-trained animals. (B) Significant effect 
of maze training on total dendritic length of Purkinje cells. (C, D) Effects of maze training and develop-
mental A1254 exposure on dendritic growth in cortical neurons. Data are presented as mean ± SEM 
(n = 17–21 neurons/group). Percent change in dendritic length as a function of maze training was calcu-
lated as the difference in dendritic length of neurons in maze-trained animals versus nonmaze-trained 
animals divided by dendritic length of neurons in maze-trained animals multiplied by 100. 
*p < 0.05, **p < 0.01, #p < 0.001 (A and B, ANOVA followed by Newman-Keuls; C and D, Wilcoxon test). 
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Figure 4. Developmental A1254 exposure increases specific [3H]-ryanodine (Ry) binding to cerebellar membranes. Binding constants (Kd and Bmax) were deter-
mined from a [3H]-ryanodine–binding curve measured in cerebellar membranes from P21 pups (A) using Scatchard analysis (B). (C) Measurements of specific 
binding of [3H]-ryanodine (5 nM) to cerebellar membranes from P21 and maze-trained P31 rats. The percent change in ryanodine binding between P21 and P31 
was calculated as the difference in Bmax between P21 and P31 divided by Bmax at P21 multiplied by 100. Data are presented as mean ± SD (n = 4). 
*p < 0.05, **p < 0.01, #p < 0.001 (ANOVA; Newman-Keuls post hoc).
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the effect on RyR2 expression was similar 
between A1254 groups, the effect on RyR1 
expression was significantly greater in the 
1 mg/kg/day A1254 group relative to the 
6 mg/kg/day A1254 group. Comparison of cere­ 
bellar expression levels of RyR1 and RyR2 
between P21 and untrained P31 rats within 
controls indicated that expression of these 
RyR isoforms did not increase with age 
(Figure 5C). As previously reported for RyR2 
(Cavallaro et al. 1997), maze training sig­
nificantly increased RyR1 and RyR2 expre­ 
ssion in controls (Figure 5D). In rats exposed 
developmentally to A1254, maze training 
also significantly increased RyR2 expression 
but significantly decreased RyR1 expression 
(Figure 5D). Comparison between groups 
of the percent change in RyR1 and RyR2 
expression as a function of maze training sug­
gested that developmental A1254 exposure 
reversed the effects of maze training on RyR1 
expression and attenuated the effects of maze 
training on RyR2 expression; these responses 
were more pronounced in the 1 mg relative to 
the 6 mg/kg/day A1254 group. 
Congener-specific PCB effects on dendritic 
growth in cultured neocortical neurons. The 
observation of similar inverted dose­related 
effects and training­dependent bipha­
sic responses of dendritic morphology and 
RyR expression in A1254­exposed animals 
suggested a causal relationship between these 
effects. We previously demonstrated that non­
coplanar PCBs possessing 2–3 chlorine ortho 
substitutions are the most potent RyR acti­
vators (Pessah et al. 2006), consistent with 
findings from other laboratories that nonco­
planar, but not coplanar, PCBs increase intra­
cellular Ca2+ in neurons (Kodavanti 2005). 
Noncoplanar PCBs at nanomolar concen­
trations interact with RyRs to dramatically 
increase their sensitivity to activation by nano­
molar Ca2+ and attenuate their sensitivity to 
inhibitory feedback by millimolar Ca2+ and 
Mg2+ (Pessah and Wong 2001). To further 
probe the relationship between PCB effects 
on dendritic growth and RyRs, we quanti­
fied dendritic growth in primary cultures of 
neocortical neurons exposed to individual 
PCB congeners with differential effects on 
RyR activity at concentrations that did not 
adversely influence cell viability in cultured 
neocortical neurons (Howard et al. 2003). 
A 48­hr exposure of cultured neocortical 
neurons (7–9 DIV) to nanomolar concen­
trations of PCB95, a congener that potently 
activates RyRs (Pessah et al. 2006), signi­ 
ficantly enhanced dendritic growth, whereas 
exposure to PCB66, a congener with little 
activity at the RyR (Pessah et al. 2006), had 
no effect on dendritic growth (Figure 6 A–D). 
Interestingly, micromolar concentrations of 
PCB95 had no net effect on dendritic growth 
compared with controls, recapitulating the 
Figure 5. Developmental A1254 exposure alters RyR expression in the cerebellum. (A) Representative 
blot of cerebellar membrane samples from P21 and maze-trained P31 rats probed with RyR antibodies. 
(B) Densitometric analyses of RyR1 and RyR2 expression in the cerebellum at P21. Band densities of sam-
ples from A1254-treated animals are plotted as percentage of mean control band densities. (C) Cerebellar 
expression of RyR1 and RyR2 as a function of age in nonmaze-trained animals. Data are presented as 
percent change in mean pixel density from P21 to P31 within each treatment group. (D) Effects of maze 
training and developmental A1254 exposure on RyR1 and RyR2 expression in the cerebellum. Data are 
presented as mean ± SEM (n ≥ 4). Asterisks associated with individual bars indicate statistically signifi-
cant differences between P21 and maze-trained P31 rats within a group; asterisks above horizontal lines 
indicate statistically significant difference between groups.
*p < 0.05, **p < 0.01, #p < 0.001 (ANOVA; Bonferroni post hoc).
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Figure 6. PCB95, but not PCB66, promotes dendritic growth in cultured neocortical neurons. Neurons 
dissociated from embryonic rat cortices were plated at high density and transfected at 6-DIV with MAP2-
GFP, which labels the somatodendritic compartment of 0.5–2% of neurons in the culture. At 7-DIV, cultures 
were treated with vehicle (0.1% DMSO), PCB66, or PCB95. Photomicrographs of GFP-positive neurons 
treated with vehicle (A), PCB95 (B), or PCB66 (C) at 250 nM. PCB95, a congener with potent RyR activity, 
significantly enhanced dendritic growth in cultured cortical neurons in a nonmonotonic fashion (B, D). In 
contrast, PCB66, a congener that lacks RyR activity, had no effect on dendritic growth in cultured corti-
cal neurons (C, D). (E) PCB95–induced dendritic growth is blocked by the ryanodine receptor antagonist 
FLA365 (10 µM). Data are presented as mean ± SEM (n = 30 neurons/condition).
**p < 0.01, #p < 0.001 (ANOVA; Newman-Keuls post hoc). 
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inverted dose­related effects of developmental 
A1254 exposure on dendritic growth in vivo. 
PCB­95–induced dendritic growth was com­
pletely blocked in the presence of the selective 
RyR antagonist FLA365 (Mack et al. 1992) 
(Figure 6E). 
Analyses of PCB levels in weanling rats 
exposed developmentally to A1254. Our 
in vitro observations strongly suggest that 
noncoplanar PCB congeners mediated the 
effects of A1254 in vivo. As an indirect test of 
this hypothesis, we measured CYP activities 
in hepatic microsomes and quantified levels 
of individual PCB congeners in the whole 
brain obtained at P31 from male and female 
littermates of animals trained in the Morris 
water maze. Total CYP content was signifi­
cantly increased by developmental A1254 
exposure at P21, but only in the 6 mg/kg/
day treatment group, and this effect was no 
longer evident at P31 (Figure 7A). EROD 
and PROD activity represent CYP isozymes 
differentially up­regulated by coplanar and 
noncoplanar PCBs, respectively (Hansen 
1999). Developmental A1254 exposure dose­
dependently increased EROD (Figure 7B) 
and PROD (Figure 7C), and these effects 
persisted until P31, although the absolute lev­
els of EROD and PROD activity decreased 
in all treatment groups with increasing age 
(Figure 7C). 
Of the 32 congeners chosen for analysis 
based on their toxicity, presence in A1254, 
abundance in environmental samples, and 
analytical capability, 30 were below the 
detection limit in brains of controls; the two 
congeners that were detected, PCB158 and 
PCB187, were found in only one of four 
samples (Table 2). In contrast, 14 congeners 
were detectable in brains from animals in the 
1 mg/kg/day A1254 group and 16 in brains 
from the 6 mg/kg/day A1254 group. These 
were predominantly ortho­substituted, non­
coplanar PCBs, and levels were significantly 
higher in the 6 mg relative to the 1 mg/kg/
day A1254 group. 
Discussion
The major findings of this study are that 
developmental PCB exposure enhanced basal 
dendritic growth but decreased experience­
dependent dendritic plasticity, and that these 
effects correlated better with altered RyR 
expression than with endocrine disruption. 
Developmental A1254 exposure signifi­
cantly enhanced dendritic growth in cerebel­
lar Purkinje cells and neocortical pyramidal 
neurons among P31 rats not trained in the 
Morris water maze, which is consistent 
with our previous observations that similar 
exposures accelerated dendritic growth in 
Purkinje cells and hippocampal CA1 pyra­
midal neurons between P21 and P60 (Lein 
et al. 2007). In Purkinje cells, this effect was 
observed among animals in the 1 mg but not 
6 mg/kg/day A1254 group, whereas in neo­
cortical neurons, responses were comparable 
between A1254 groups. The reason for the 
different dose–response relationship in differ­
ent brain regions is not known. Possibilities 
include regional differences in RyR regula­
tion (Berridge 2006; De Crescenzo et al. 
2006; Hertle and Yeckel 2007) or differential 
upregulation of cytochrome P450 enzymes 
by AhR ligands in the cerebellum versus neo­
cortex (Iba et al. 2003), which could result in 
regional differences in PCB toxicodynamics 
and toxicokinetics, respectively. 
Previous studies have shown that expe­
rience increases dendritic complexity 
(Greenough et al. 1979), and we observed 
that among controls, training in the Morris 
water maze significantly increased dendritic 
length in both Purkinje cells and neocortical 
neurons. However, maze training caused no 
change in dendritic length in the 6 mg/kg/day 
A1254 group and significant dendritic retrac­
tion in the 1 mg/kg/day A1254 treatment 
group. Structural plasticity of dendrites is 
considered the cellular substrate of learning 
and memory (Leuner and Shors 2004), and 
we observed that developmental A1254 expo­
sure caused subtle but statistically significant 
delays in learning and memory that exhibited 
an inverted dose­related response similar to 
that observed for experience­dependent plas­
ticity in A1254­treated animals. That these 
behavioral effects may be of biological sig­
nificance is suggested by comparison with 
the human literature, which similarly demon­
strates an association between developmental 
PCB exposures and subtle effects on cognitive 
function that may be overcome by training or 
increasing age (Carpenter 2006; Korrick and 
Sagiv 2008; Schantz et al. 2003). Such subtle 
effects may have significant biological and 
social costs when considered at the population 
level (Grandjean et al. 2007; Weiss 2000). 
It is widely postulated that PCB develop­ 
mental neurotoxicity is mediated by endo­
crine disruption (Koibuchi and Iwasaki 2006; 
Roman 2007; Zoeller 2007). Developmental 
PCB exposure is reported to modulate sys­
temic estrogen levels (Meerts et al. 2004), 
increase estrogen sensitivity (Ceccatelli et al. 
2006), and compete for binding to the estro­
gen receptor (DeCastro et al. 2006), yet we 
observed no A1254­related effects on plasma 
levels of estradiol or testosterone and only 
minor effects on estrogen­ and androgen­
dependent developmental end points. The 
discrepancies probably reflect differences in 
doses, which were generally much lower in 
our study, or congener profiles. As previously 
reported (Crofton et al. 2000; Roegge et al. 
2004; Zoeller et al. 2000), developmental 
A1254 exposure significantly decreased serum 
thyroid hormone levels. However, it seems 
unlikely that PCB effects on dendritic growth 
were due to hypothyroxi nemia, because 
a) neonatal hypothyroidism decreases basal 
dendritic growth (Ruiz­Marcos et al. 1994; 
Figure 7. A1254 induction of CYP expression and activity in the liver is dose and age dependent. (A) Microsomal CYP content and (B) EROD or (C) PROD activi-
ties were measured in liver at P21 and P31. EROD and PROD were chosen as biomarkers of exposure to coplanar and noncoplanar PCBs, respectively. Liver CYP 
content was significantly increased relative to controls in the 6 mg/kg treatment group on P21. Developmental A1254 exposure dose-dependently increased EROD 
and PROD activity at P21 and P31; the increase in PROD activity was significantly different from control only in the 6 mg/kg/day A1254 group. Data are presented 
as mean ± SEM (n = 5–7/group at P21; n = 10–13/group at P31). 
*p < 0.05, **p < 0.01, #p < 0.001 (ANOVA; Newman-Keuls post hoc).
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Uylings et al. 1994), whereas developmental 
PCB exposure significantly enhanced basal 
dendritic growth; and b) PCB effects on den­
dritic growth were recapitulated in cultured 
neocortical neurons removed from systemic 
thyroid hormone influence. We recently dem­
onstrated that PCB95 significantly disrupts the 
normal balance of excitatory and inhibitory 
neurotransmission in the auditory cortex at 
a dose that has no measurable effect on audi­
tory brain stem responses (ABRs) (Kenet et al. 
2007), which is a confirmed T4­dependent 
target of PCB (Crofton and Zoeller 2005). 
Although we cannot preclude the possibility 
that PCBs influence thyroid hormone signal­
ing downstream of cognate receptors (Zoeller 
2007), our data suggest that endocrine disrup­
tion is not the sole mechanism underlying 
PCB effects on neuronal connectivity. Another 
critical determinant of dendritic morphology 
is Ca2+ signaling (Lohmann and Wong 2005; 
Redmond and Ghosh 2005). Kodavanti and 
colleagues (Kodavanti 2005) demonstrated 
that noncoplanar, but not coplanar, PCBs 
increase intracellular Ca2+ in neurons. Several 
mechanisms have been shown to mediate this 
response (Kodavanti 2005; Mariussen and 
Fonnum 2006), but one of the most sensitive 
is RyR sensitization (Pessah and Wong 2001). 
RyR­mediated signals influence neuronal 
excitability, regulate synaptic plasticity (Collin 
et al. 2005; Conti et al. 2004; Raymond and 
Redman 2006; Shimuta et al. 2001), and acti­
vate cytosolic (Berridge 2006) and nuclear 
transcriptional events (Dolmetsch et al. 1998; 
Li et al. 1998) implicated in activity­depen­
dent dendritic growth (Aizawa et al. 2004; 
Redmond et al. 2002; Wayman et al. 2006). 
Here we show that developmental A1254 
exposure dose­dependently increased RyR 
activity in the cerebellum as determined by 
[3H]­ryanodine receptor­binding analysis. This 
is most likely the result of dose­dependent 
accumulation of PCBs in the brain. The most 
abundant congeners found in the brain were 
noncoplanar, which are potent sensitizers of 
RyR channels (Pessah et al. 2006). One pos­
sible consequence of chronic RyR sensitiza­
tion is altered fidelity of Ca2+ signaling (Marks 
2002). In our study, elevated [3H]­ryanodine 
binding was closely associated with differential 
expression of RyR1 and RyR2 isoforms within 
the cerebellum, and changes in expression of 
isoforms were highly dependent on A1254 
dose and training status. Interestingly, effects 
of dose and training on RyR expression closely 
paralleled their effects on dendritic morphol­
ogy. Given the fundamental role of RyR in 
Ca2+ signaling and the critical influence of 
Ca2+ signaling on basal and activity­ dependent 
dendritic growth, these data suggest that 
PCB effects on RyR could be largely respon­
sible for the effects of developmental A1254 
exposure on neuronal connectivity observed 
in weanling rats. In support of this hypoth­
esis, nanomolar concentrations of PCB95, a 
congener that potently activates RyRs (Pessah 
et al. 2006), enhanced dendritic growth in pri­
mary cultures of neocortical neurons, whereas 
similar concentrations of PCB66, a congener 
with negligible effects on RyR activity, had no 
effect on dendritic growth. Moreover, phar­
macologic antagonism of RyR activity blocked 
PCB95–enhanced dendritic growth. That 
PCB­mediated RyR dysfunction modulates 
development of neuronal networks is further 
supported by our previous demonstration that 
developmental exposure to PCB95 significantly 
enhanced the ratio of excitatory to inhibitory 
currents within the primary auditory cortex 
(A1) of weanling rats, which was associated 
with irregularly shaped topographic organiza­
tion of A1 and disruption of the critical period 
plasticity that underlies normal postnatal audi­
tory system develop ment (Kenet et al. 2007). 
It is plausible that these effects reflect changes 
in basal and activity­driven dendritic complex­
ity, as demonstrated in the present study. 
Based on our findings, we propose a novel 
model of PCB developmental neurotoxicity 
in which noncoplanar PCBs sensitize RyR 
activity and alter Ca2+­dependent signal­
ing mechanisms that link neuronal activity 
to dendritic growth and plasticity. A critical 
role for RyRs in PCB interference with neu­
ronal connectivity suggests several explana­
tions for the inverted dose­related effects as 
well as training­dependent biphasic outcomes 
in dendritic morphology. First, chronic RyR 
sensitization alters RyR expression, and conse­
quently, downstream Ca2+­dependent events 
that regulate dendritic growth in an inverted 
dose­related manner, perhaps because of 
negative feedback at the higher A1254 dose. 
Second, intracellular Ca2+ promotes dendritic 
growth in a concentration­dependent manner 
in early neuronal development (Lohmann 
and Wong 2005). In later neuronal develop­
ment, however, moderate increases in Ca2+ 
promote dendritic growth, whereas large 
increases cause dendritic retraction (Lohmann 
and Wong 2005; Segal et al. 2000). Thus, 
increasing PCB doses may increase intracel­
lular Ca2+ from concentrations that promote 
dendritic growth to those that cause dendritic 
retraction. Furthermore, training­induced 
increases in intracellular Ca2+ superimposed 
on a background of PCB exposure may push 
Ca2+ concentrations towards those that cause 
dendrite retraction. Although further studies 
are required to test these mechanistic hypoth­
eses, the observation of an inverted (or non­
monotonic) dose–response relationship has 
global regulatory implications as screening 
and testing programs for endocrine disruption 
and developmental neurotoxicity that empha­
size very high doses of test chemicals with lit­
tle to no acknowledgement of the importance 
of nonmonotonic dose–response relationships 
are finalized (Kimmel and Makris 2001).
The relevance of our findings to human 
health is suggested by several considerations. 
First, altered dendritic growth and impaired 
experience­dependent dendritic plasticity are 
thought to contribute to the clinical manifes­
tations of various environmentally induced 
neurodevelopmental disorders in humans 
(Connors et al. 2008; Pardo and Eberhart 
2007; Zoghbi 2003). Second, congener­
specific analyses of brains from weanling rats 
in the 1 mg/kg/day A1254 group identified 
predominantly ortho­substituted congeners 
Table 2. Congener-specific analysis of P31 brains.
  PCB (ng/g wet weight)   PCB (ng/g lipid)
A1254 (mg/kg/day) 0 1 6 0 1 6
Mono-orthoa
 PCB70 BDL 0.5 ± 0.2 0.6 ± 0.2 BDL 8.8 ± 2.9 11 ± 4
 PCB74 BDL 2.0 ± 0.9 2.8 ± 1.3 BDL 36 ± 16 50 ± 24
 PCB118 BDL 29 ± 6.1 78 ± 28 **,# BDL 537 ± 103 1,398 ± 517*,#
 PCB105 BDL 11 ± 3.0 23 ± 11* BDL 199 ± 52 408 ± 208
 PCB156 BDL 4.3 ± 1.1* 18 ± 2.0**,# BDL 80 ± 22* 329 ± 41**,#
 PCB189 BDL BDL 0.8 ± 0.3* BDL BDL 14 ± 5*
Di-orthoa 
 PCB99 BDL 22 ± 3.0* 83 ± 10**,# BDL 398 ± 44* 1,479 ± 200**,#
 PCB138 BDL 30 ± 1.1* 133 ± 18**,# BDL 553 ± 18 2,369 ± 357**,#
 PCB153 BDL 22 ± 0.7 110 ± 17**,# BDL 412 ± 15  1,964 ± 336**,#
 PCB128 BDL 5.3 ± 0.8* 10 ± 2.7**,# BDL 97 ± 13* 171 ± 49**,#
 PCB180 BDL 3.4 ± 0.3* 15 ± 2.0**,# BDL 62 ± 5 275 ± 39**,#
 PCB170 BDL 2.8 ± 0.2 13 ± 2.0**,# BDL 52 ± 4 230 ± 40**,#
 PCB158 1.1b 3.9 ± 0.2* 14 ± 2.0**,# 23.7b 72 ± 5 256 ± 39**,#
 PCB166 BDL BDL 1.3 ± 0.2**,# BDL BDL 22 ± 3**,#
Tri-ortho 
 PCB187 1.0b 1.9 ± 0.3* 6.2 ± 0.7**,# 22.6b 35 ± 5 111 ± 14**,#
 PCB183 BDL 1.0 ± 0.1* 3.7 ± 0.4**,# BDL 19 ± 3* 66 ± 8**,#
BDL, below the detection limit.
aPCB congeners below detection limit in all samples: mono-ortho-substituted congeners 8, 28, 60, 66, and 114; di-ortho-
substituted congeners 44, 49, 52, 82, 87, and 101; non-ortho-substituted congeners 37, 77, 126, and 169. Mean ± SEM (n 
= 4 per group). bConcentration detected in one of four samples. *p < 0.05 relative to control; **p < 0.01 relative to control; 
#p < 0.05 relative to 1 mg/kg/day A1254. 
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at concentrations ranging from 0.5 ng to 
3 ng/g wet weight. Analyses of PCB levels in 
human brains obtained from the general adult 
population similarly identified predominantly 
ortho­substituted congeners at concentrations 
ranging from 0.07 ng to 12 ng/g wet weight 
(Chu et al. 2003; Covaci et al. 2002; Dewailly 
et al. 1999). Ortho­substituted congeners with 
the highest activity towards RyRs, including 
PCB95, collectively represent 40–50% of 
total PCBs currently found in environmental 
and biotic samples, and their net effects are 
likely to be additive (Pessah et al. 2006). Even 
lower levels of PCB exposure might amplify 
adverse effects in genetically susceptible indi­
viduals (Campbell et al. 2006), particularly if 
both the genetic factor and PCBs converge to 
dysregulate the same developmental process. 
Interestingly, genes that encode Ca2+­regulated 
signaling proteins involved in synapse for­
mation and dendritic growth are implicated 
in neurodevelopmental disorders (Krey and 
Dolmetsch 2007). Considered together, these 
observations identify PCBs, particularly ortho­
substituted PCBs with high RyR activity, as 
candidate environmental risk factors in neuro­
developmental disorders and provide impor­
tant new clues about the possible role of RyR 
in contributing to environmentally triggered 
neurodevelopmental deficits. 
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